CM
SAGE
Caption Management’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 947 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1014 |
|
|
2024
Q4 | – | Sell |
-500
| Closed | -$3.61K | – | 936 |
|
|
2024
Q3 | $3.61K | Hold |
500
| – | – | ﹤0.01% | 418 |
|
|
2024
Q2 | $5.43K | Sell |
500
-4,390
| -90% | -$47.7K | ﹤0.01% | 379 |
|
|
2024
Q1 | $91.6K | Buy |
4,890
+1,820
| +59% | +$34.1K | ﹤0.01% | 312 |
|
|
2023
Q4 | $66.5K | Sell |
3,070
-18,800
| -86% | -$407K | ﹤0.01% | 368 |
|
|
2023
Q3 | $450K | Buy |
+21,870
| New | +$450K | 0.01% | 225 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 704 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 757 |
|
|
2022
Q3 | – | Sell |
-4,362
| Closed | -$141K | – | 839 |
|
|
2022
Q2 | $141K | Sell |
4,362
-59,935
| -93% | -$1.94M | ﹤0.01% | 377 |
|
|
2022
Q1 | $2.13M | Sell |
64,297
-2,324
| -3% | -$76.9K | 0.03% | 154 |
|
|
2021
Q4 | $2.84M | Buy |
+66,621
| New | +$2.84M | 0.03% | 136 |
|
|
2021
Q3 | – | Sell |
-139,600
| Closed | -$7.93M | – | 865 |
|
|
2021
Q2 | $7.93M | Buy |
139,600
+128,770
| +1,189% | +$7.32M | 0.1% | 32 |
|
|
2021
Q1 | $810K | Buy |
+10,830
| New | +$810K | 0.02% | 180 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 575 |
|
|
2020
Q1 | – | Sell |
-65,300
| Closed | -$4.72M | – | 536 |
|
|
2019
Q4 | $4.72M | Buy |
+65,300
| New | +$4.72M | 0.16% | 21 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 447 |
|
|
2019
Q2 | – | Sell |
-40,600
| Closed | -$6.46M | – | 410 |
|
|
2019
Q1 | $6.46M | Buy |
40,600
+17,750
| +78% | +$2.82M | 0.36% | 7 |
|
|
2018
Q4 | $2.19M | Buy |
+22,850
| New | +$2.19M | 0.17% | 36 |
|